PAA 2.33% 21.0¢ pharmaust limited

Ann: Extension Study Begins, Analysis Suggests Survival Benefit, page-158

  1. 522 Posts.
    lightbulb Created with Sketch. 84
    Agree Cashie, it would be fantastic for MND/ALS sufferers.

    However I do recall reading that once a neuron is damaged/destroyed it can't be repaired. I believe neuronal replacement doesn't occur.

    I presume that BP would not like this as much either as they generally would not want a cure. I expect their preference would be for individuals to be on the medication for the rest of their life. Morrally this isn't right, but then we are talking about BP.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
21.0¢
Change
-0.005(2.33%)
Mkt cap ! $93.45M
Open High Low Value Volume
21.0¢ 21.5¢ 21.0¢ $85.73K 407.4K

Buyers (Bids)

No. Vol. Price($)
2 53482 21.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.5¢ 278844 4
View Market Depth
Last trade - 15.15pm 19/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.